BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Resignation of Mr Mohith Kumar Khandelwal as Company Secretary & Compliance Officer of the company w.e.f. January 29, 2026.
BALAXI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mr. Mohith Kumar Khandelwal has resigned from the position of Company Secretary and Compliance Officer of Balaxi Pharmaceuticals Limited, effective January 29, 2026. No reason for the resignation has been disclosed in the filing. The Company Secretary is a Key Managerial Personnel (KMP) as per the Companies Act, responsible for ensuring regulatory compliance and board-related processes. The company has not yet announced a replacement, and shareholders will now look to the board for an update on succession planning for this critical compliance role.
A Company Secretary resignation without a named successor may temporarily create uncertainty around compliance and disclosure timelines, but the impact is generally low unless it signals broader governance issues.